Summary Normal growth and development, as well as the prevention of overweight, are major goals in the treatment of paediatric patients with insulin-dependent diabetes mellitus (IDDM). We therefore evaluated longitudinally the anthropometric measurements of height and weight, as well as bone age, in an unselected group of 389 patients with IDDM treated at one institution. In order to identify genetic influences on these parameters, height and weight were determined in 186unaffected siblings and 177 pairs Of parents. At diagnosis, patients were slightly taller than average (median z score: + 0.37). During the subsequent course of diabetes, age-adjusted heights decreased progressively for the first 9 years, catching up again after more than 10 years of diabetes. Bone ages were progressively retarded with increasing duration of diabetes. In 76 patients of 18 years or older, median z-score for height was + 0.30, not different from their unaffected siblings (median z-score: + 0.22). The correlation with midparental height was identical for diabetic and nondiabetic siblings (r = 0.43). In contrast, children with diabetes were significantly heavier (z-score for weight: + 0.74 compared to + 0.34 in unaffected siblings; p < 0.002). Obesity developed primarily during and after puberty. We conclude that: 1)during the course of diabetes, longitudinal growth is temporarily reduced and maturation is delayed in children with diabetes compared to unaffected siblings. However, this effect of diabetes is transient and small compared to genetic influences on height in an individual child. 2) As a group, children with IDDM become significantly overweight, which is likely to increase the cardiovascular risk during adulthood [Diabetologia (1994) 37: 925-929].
standing diabetes have been repeatedly recognised as overweight [3] [4] [5] .
We previously published a prospective multi-centre study, comparing diabetic children to a control group of 102 healthy children. In 49 patients followed-up for at least 3 years after the onset of diabetes, reduced height together with increased weight was shown [3] . The present study is based on a much larger, unselected group of patients treated at a single institution, encompassing the entire paediatric age range from early childhood to young adults. It has been repeatedly hypothesized that rapidly growing, tall children bear an increased risk for IDDM. Unfortunately, previous studies were often hampered by using unsuitable reference populations [6] [7] [8] . In addition to the individual genetic background, regional differences and secular changes both in height as well as tempo of growth and maturation, have to be considered.
In order to discriminate between genetic and metabolic influences on stature in diabetic children, unaffected first-degree relatives provide an ideal control population, which has rarely been evaluated previously [9] . Therefore, the aim of our study was to longitudinally follow-up height, weight and body mass index in an unselected group of paediatric patients with IDDM, treated at a single centre, and relate these data to the respective measurements in a group of nondiabetic siblings and parents.
Patients and methods
We evaluated 389 patients with IDDM (201 girls, 188 boys), who had been treated and followed up at our institution. The majority of data was collected between 1980 and 1992 (92.4 %). Of a total of 421 patient-records available , 32 patients were excluded from analysis for the following reasons: one or two parents of non-German descent (n = 25), coexistence of celiac disease (n = 6) or long-term steroid replacement therapy for adreno-genital syndrome (n = 1). All patients were treated by 2-4 daily injections of a free mixture of regular and NPH insulin. Both in-patient as well as out-patient care was provided by the same group of doctors, nurses and dieticians. The therapeutic regimen used at our centre and the degree of metabolic control achieved have been published recently [10, 11] .
Height was determined by a Harpenden stadiometer up to 1989 and subsequently by a newly-developed electronic stadiometer with automatic recalibration (Fa. Busse, Ulm, Germany; inter-observer coefficient of variation: 0.1%). Bone ages were determined from an X ray of the left hand and wrist according to Greulich and Pyle [12] . All parents and siblings were asked to participate in this study. Families were included only if both parents were non-diabetic and available for measurement; similarly, diabetic siblings were excluded. Complete data were available for 177 pairs of parents and t86 unaffected siblings. In addition to the information described in this paper, blood pressure was recorded in all subjects.
Statistical analysis
As height and weight are dependent on both age and sex, z scores (SD scores) were calculated based on the data from the Zurich longitudinal growth study ([13] ; data for BMI were kindly supplied by A.Prader). Among the anthropometric studies published so far, these data provide a suitable comparison for height and weight in children from our region 9 In order to eliminate a possible bias due to variation in the number of examinations per year, all measurements from yearly intervals, based either on chronological age or on duration of diabetes, were averaged for each patient. Data were collected using a custom-designed computer program previously developed at our institution [10] . Relevant data were transferred to a spreadsheet program (Lotus Symphony). For statistical evaluation, non-parametric tests were applied (Wilcox 9 Spearman's coefficient of correlation; SAS software package). Group data were expressed as median [25 th In order to clarify whether reduced longitudinal growth and progressive overweight occur at specific ages, weight, height and BMI of diabetic children were ..-,~~ ...... A significantly positive correlation between bone-age retardation and the duration of diabetes was present (r= 0.28, p < 0.001) 927 related to their chronological age (Fig. 2) (Fig. 3) . These values were significantly above the reference data from the Zurich study in healthy children (p < 0.001). If the most recent measurements in children with diabetes were compared to the respective measurements in their unaffected siblings, the z score for height was not significantly different (+ 0.08 in diabetic compared to + 0.22 in unaffected siblings). In contrast, weight and BMI were significantly elevated in affected children We next asked how parental height and weight is related to height and weight in diabetic children. Both mid-parental height [(father + mother)/2] as well as mid-parental weight were highly significantly related to the respective SD scores in their diabetic children (r = + 0.43, p < 0.0001 for height and r = + 0.23, p < 0.002 for weight). Identical coefficients of correlation were found between the parents and their unaffected children (r = + 0.43,p < 0.0001 for height and r = + 0.30,p < 0.0001 for weight). When boys and girls were evaluated separately, weight SD score was significantly correlated with mid-parental weight in unaffected boys (r = + 0.35, p < 0.0006) as well as unaffected girls (r = + 0.26, p < 0.02). Surprisingly, in diabetic girls, no such relationship was present: the coefficient of correlation with mid-parental weight was r = + 0.34,p < 0.001 for diabetic boys compared to r = + 0.14, NS, in diabetic girls.
In order to test the hypothesis that the tempo of growth and development is retarded in diabetic children, 514 determinations of bone ages were evaluated in relation to chronological age and duration of diabetes (Fig. 4) . At the onset of diabetes, bone age was not retarded (BA-CA: -0.125 years [-0.64-+ 0.32], n = 110). However, during the subsequent course of diabetes, bone ages were progressively delayed, resulting in a significantly positive correlation between bone age retardation and the duration or diabetes (r = + 0.28, p < 0.001). No X rays for the determination of bone ages in non-diabetic siblings were available.
Discussion
Several studies have reported that at the onset of diabetes children are taller than expected [2, 6, 7, 9, 14] . However, normal [9] or even reduced height [15] at diagnosis of diabetes have also been reported, the latter finding in a study on identical twins followed up prospectively. In our study, including nearly 400 unselected patients from our hospital, height of both patients as well as their siblings fell above the reference data for height in healthy children. This finding is consistent with two interpretations: 1) the Zurich control group, originally consisting of more than 400 children born between 1950 and 1960, and followed up longitudinally for 20 years, may not be representative for children born in Southern Germany 15-20 years later [13] . To exclude this possibility, a large sample of height measurements in unaffected control children, representative for our area, would be necessary. Such data are currently not available. However, in our previous study, we included a control group of 102 healthy children [3] . Height and weight did not differ significantly from expected values. 2) In agreement with reports in the literature, increased height in diabetic children as well as their Siblings is compatible with the notion that genetically determined tall stature and rapid growth are risk factors for the development of IDDM [6, 7] .
In our study, age-and sex-standardized height in diabetic children was not significantly different from the respective measurements in their unaffected siblings. In addition, height was not significantly different between boys and girls. This agrees with several recent publications [8, 9, 14] , while other studies have reported boys with newly-diagnosed diabetes to be taller compared to girls [6, 7] .
During the early course of diabetes, diabetic children progressively lose height, and bone ages are increasingly retarded. Beyond 10 years of diabetes, children catch up again, and height in a subgroup of 76 patients followed up to final height (assumed with a chronological age of 18 years or more) was not reduced. These findings are compatible with the assumption of a transient retardation in growth and development during pre-pubertal and pubertal years. This agrees with previous publications on the early course of diabetes [3, 16] , although only few long-term follow-up studies are available so far. In the unselected group of all patients treated at our institution, R. W. Holl et al.: Genetic influences on stature in diabetic children short stature is not a relevant problem. However, subgroups of patients with insufficient metabolic control or coexistent undiagnosed celiac disease or hypothyroidism may not reach their genetic height potential.
Our data demonstrate significant and progressive overweight in paediatric patients with diabetes. Obese, but otherwise healthy children tend to be taller than average, have accelerated bone maturation and experience early puberty [17] [18] [19] . Therefore, in comparison, delayed growth and maturation in children with diabetes is even more remarkable. Overweight is significantly related to the development of hypertension in our diabetic patients [20] and represents a wellestablished risk factor for cardiovascular disease in diabetic patients [21] . In healthy children, overweight is associated with reduced pituitary secretion of GH, while serum levels of GH-binding protein are high and circulating concentrations of IGF-I are in the highnormal range [22] . In contrast, in diabetic subjects, GH secretion is elevated, while GH-BP and IGF-I are reduced [23] [24] [25] . These alterations in the GH-IGF-Iaxis provide further evidence that the hormonal regulation of longitudinal growth is altered in children suffering from diabetes.
It is likely that the degree of metabolic control is related to impaired longitudinal growth as well as the development of obesity in patients with diabetes. However, it is very difficult to accurately assess the quality of blood glucose control over long periods, as a considerable number of children included in this study developed diabetes before the advent of glycated haemoglobin as a routine long-term measurement of metabolic control, and the number of control visits naturally differs among patients. Not surprisingly, conflicting results have been published on the effect of glycaemic control on growth velocity in diabetic children [4, 5, 16, 26] . In order to avoid a bias due to these problems, we did not attempt to relate anthropometric data to metabolic control in this study. A likely explanation for the development of overweight may be provided by recurrent hypoglycaemic episodes leading to additional calorie intake. The initiation of tight metabolic control in previously poorly-controlled diabetic patients is associated with weight gain, as recently demonstrated in the Diabetes Control and Complications Trial [27] .
Our study demonstrates that growth and maturation in children with IDDM are slightly delayed, but adult height is not compromised. Genetic factors affect height to a similar degree in children both with and without diabetes. In contrast, additional factors specific for diabetes contribute to increased weight gain in diabetic children and adolescents. The development of overweight represents a major problem for the long-term outcome in diabetic patients. Future research will be directed towards identifying sub-populations at increased risk, as well as towards the devel-
